Roxadustat (808118-40-3): High-Purity API for Pharmaceutical Applications

Discover the critical role of this HIF prolyl-hydroxylase inhibitor in advanced anemia treatment.

Get a Quote & Sample

Advantages

Enhanced Efficacy

As a HIF prolyl-hydroxylase inhibitor, this compound offers a novel therapeutic approach for anemia, distinct from traditional ESAs. Its ability to stabilize HIF leads to a coordinated erythropoietic response.

High Purity and Quality

Sourced from reputable manufacturers, the API boasts high purity, crucial for pharmaceutical applications and meeting stringent quality standards. Reliable buying Roxadustat online ensures consistent product quality.

Therapeutic Versatility

Beyond CKD-related anemia, research indicates potential applications in other conditions, making it a valuable asset for pharmaceutical companies engaged in drug development. Exploring pharmaceutical intermediate sourcing is key.

Key Applications

Anemia Treatment

Used for treating symptomatic anemia in adults with chronic kidney disease, both dialysis-dependent and non-dialysis-dependent patients. This highlights the importance of securing a stable Roxadustat API synthesis supply.

Pharmaceutical Research

Serves as a critical research chemical and reference standard for pharmaceutical companies developing new anemia therapies and studying the HIF pathway. Sourcing this compound is vital for research endeavors.

Drug Discovery & Development

Its unique mechanism makes it a subject of interest in drug discovery, particularly for conditions related to hypoxia and erythropoiesis. Effective pharmaceutical intermediate sourcing is key here.

Biochemical Assays

Utilized in various biochemical assays and studies to understand the complex mechanisms of HIF stabilization and its downstream effects on cellular processes.